Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|August 6, 2011
Glucocorticoid receptor and breast cancerMyriam Vilasco, Laudine Communal, Najat Mourra, et al.
Journal of Market Access & Health Policy|October 17, 2017
Development of an instrument evaluating the impact of surgeon-patient relationship in patients on sick leaveThierry Dubert, Cedric Girault, Alexandre Kilink, et al.
Breast Cancer Research and Treatment|October 30, 2013
Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissueMyriam Vilasco, Laudine Communal, Justine Hugon-Rodin, et al.
Breast Cancer Research and Treatment|March 10, 2016
Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissueMyriam Vilasco, Laudine Communal, Justine Hugon-Rodin, et al.
Human Reproduction (Oxford, England)|June 29, 2012
Ulipristal acetate does not impact human normal breast tissueLaudine Communal, Myriam Vilasco, Justine Hugon-Rodin, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected liversMyriam Vilasco, Esther Larrea, Damien Vitour, et al.
Breast Cancer Research and Treatment|February 22, 2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cellsAurélie Courtin, Laudine Communal, Myriam Vilasco, et al.
The Journal of General Virology|November 14, 2006
A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cellsAdrien Breiman, Damien Vitour, Myriam Vilasco, et al.
The Journal of Biological Chemistry|June 24, 2009
Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVSDamien Vitour, Stéphanie Dabo, Malek Ahmadi Pour, et al.
Pageof 2